A growing income and long-term capital growth by investing nearly two thirds in UK equities and the rest in UK investment grade corporate bonds and gilts.
Name | % Net Assets |
---|---|
UK Treas 2.500 Apr 16 20 I/L | 9.8% |
UK Treas 2.500 Jul 26 16 I/L | 7.6% |
Glaxosmithkline | 4.0% |
Royal Dutch Shell | 3.7% |
BP | 3.5% |
HSBC Holdings | 2.9% |
Vodafone | 2.9% |
Unilever | 2.3% |
ASTRAZENECA | 2.1% |
Signet Jewelers | 1.7% |
Key | % Net Assets |
---|---|
UK Treas 2.500 Apr 16 20 I/L | 9.8% |
UK Treas 2.500 Jul 26 16 I/L | 7.6% |
Glaxosmithkline | 4.0% |
Royal Dutch Shell | 3.7% |
Other | 74.9% |
Date | 21-Nov-2024 |
---|---|
Bid | 227.04p |
Offer | 227.04p |
Currency | GBP |
Change | 0.030p |
% | 0.01% |
YTD change | 12.68p |
YTD % | 5.92% |
Fund Inception | 23/05/2005 |
---|---|
Fund Manager | n/a |
TER | - |
Minimum Investment | |
---|---|
Initial | n/a |
Additional | n/a |
Savings | n/a |
Charges | |
---|---|
Initial | n/a |
Annual Mang't | n/a |
Exit | n/a |
Name | % |
---|---|
No risk data available. |
You are here: research